Jan Eva Doran

871 total citations
23 papers, 656 citations indexed

About

Jan Eva Doran is a scholar working on Surgery, Epidemiology and Critical Care and Intensive Care Medicine. According to data from OpenAlex, Jan Eva Doran has authored 23 papers receiving a total of 656 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Surgery, 6 papers in Epidemiology and 5 papers in Critical Care and Intensive Care Medicine. Recurrent topics in Jan Eva Doran's work include Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Cell Adhesion Molecules Research (4 papers). Jan Eva Doran is often cited by papers focused on Trauma, Hemostasis, Coagulopathy, Resuscitation (4 papers), Sepsis Diagnosis and Treatment (4 papers) and Cell Adhesion Molecules Research (4 papers). Jan Eva Doran collaborates with scholars based in United States, Switzerland and Austria. Jan Eva Doran's co-authors include P Lundsgaard-Hansen, B. Blauhut, Christian Groß, Peter Bettelheim, Wolfgang Harringer, Michael T. Roberts, Arlie R. Mansberger, Alphonse Hubsch, Dasja Pajkrt and Marcel Levi and has published in prestigious journals such as Blood, Annals of Surgery and Critical Care Medicine.

In The Last Decade

Jan Eva Doran

22 papers receiving 613 citations

Peers

Countries citing papers authored by Jan Eva Doran

Since Specialization

Citations

This map shows the geographic impact of Jan Eva Doran's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Eva Doran with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Eva Doran more than expected).

Fields of papers citing papers by Jan Eva Doran

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Eva Doran. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Eva Doran. The network helps show where Jan Eva Doran may publish in the future.

Co-authorship network of co-authors of Jan Eva Doran

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Eva Doran. A scholar is included among the top collaborators of Jan Eva Doran based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Eva Doran. Jan Eva Doran is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Safety and Efficacy of Bortezomib in Multiple Myeloma Patients with Renal Failure Requiring Dialysis. 2005 ·Blood ·Asher Chanan‐Khan, PG Richardson, Sagar Lonial, Don L. Siegel, Sundar Jagannath, (unknown), Jan Eva Doran, Seema Singhal	10
2	Differential Effects of Reconstituted High-density Lipoprotein on Coagulation, Fibrinolysis and Platelet Activation during Human Endotoxemia 1997 ·Thrombosis and Haemostasis ·Dasja Pajkrt, P. Lerch, Tom van der Poll, Marcel Levi, (unknown), Jan Eva Doran, (unknown), A. van den Ende, Jan W. ten Cate, Sander J. H. van Deventer	75
3	Pharmacokinetics of reconstituted human high-density lipoprotein in pigs after hemorrhagic shock with resuscitation 1996 ·Critical Care Medicine ·Joseph T. DiPiro, Jorge I. Cué, (unknown), Michael L. Hawkins, Jan Eva Doran, (unknown)	11
4	Reconstituted High-Density Lipoprotein Reduces LPS-Stimulated TNFα 1995 ·Journal of Surgical Research ·(unknown), Alphonse Hubsch, (unknown), Jan Eva Doran	40
5	Comparison of the effects of aprotinin and tranexamic acid on blood loss and related variables after cardiopulmonary bypass 1994 ·Journal of Thoracic and Cardiovascular Surgery ·B. Blauhut, Wolfgang Harringer, Peter Bettelheim, Jan Eva Doran, (unknown), P Lundsgaard-Hansen	99
6	Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass 1991 ·Journal of Thoracic and Cardiovascular Surgery ·B. Blauhut, Christian Groß, (unknown), Jan Eva Doran, (unknown), P Lundsgaard-Hansen	196
7	Current Status of Fibronectin in Transfusion Medicine: Focus on Clinical Studies 1991 ·Vox Sanguinis ·(unknown), Jan Eva Doran	4
8	Current Status of Fibronectin in Transfusion Medicine: Focus on Clinical Studies 1991 ·Vox Sanguinis ·(unknown), Jan Eva Doran	2
9	Ontogeny of the humoral response to group A streptococcal carbohydrate: Class and IgG subclass composition of antibodies in children 1990 ·European Journal of Immunology ·Andreas Morell, Jan Eva Doran, F Skvaril	10
10	Effects of aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass 1990 ·Journal of Cardiothoracic Anesthesia ·B. Blauhut, (unknown), (unknown), P Brücke, Jan Eva Doran, (unknown), P Lundsgaard-Hansen, (unknown)	0
11	The Influence of Fibronectin Administration on the Incidence of Sepsis and Septic Mortality in Severely Injured Patients 1989 ·Annals of Surgery ·Arlie R. Mansberger, Jan Eva Doran, Richard C. Treat, (unknown), J. Russell May, (unknown), Marilyn S. Horowitz, Bernard Horowitz, Rob Shulman	16
12	Long-term Follow-up of Patients with Biopsy-proven Benign Breast Disease 1988 ·Annals of Surgery ·Hans‐Beat Ris, (unknown), (unknown), Jan Eva Doran, Arthur Zimmermann	6
13	Purified Fibronectin Administration to Patients with Severe Abdominal Infections 1985 ·Annals of Surgery ·P Lundsgaard-Hansen, Jan Eva Doran, (unknown), (unknown), J.‐J. Morgenthaler, Peter Späth	38
14	What Is the Theoretical Basis for the Therapeutic Use of Cryoprecipitates as a Source of Fibronectin? 1985 ·Vox Sanguinis ·Jean‐Pierre Allain, A.F.H. Britten, B Brodin, (unknown), Jan Eva Doran, Deane F. Mosher, Jan A. van Mourik, Thomas M. Saba, Frank A. Blumenstock, Edward L. Snyder	6
15	A Critical Assessment of Fibronectin's Opsonic Role for Bacteria and Microaggregates 1983 ·Vox Sanguinis ·Jan Eva Doran	32
16	A Competitive Inhibition Assay for Gelatin Binding Fibronectin 1983 ·Vox Sanguinis ·Jan Eva Doran, (unknown), (unknown), J. D. Wynn, Arlie R. Mansberger	16
17	A Critical Assessment of Fibronectin’s Opsonic Role forBacteria and Microaggregates 1983 ·Vox Sanguinis ·Jan Eva Doran	2
18	Clinical response to cold insoluble globulin replacement in a patient with sepsis and thermal injury 1981 ·The American Journal of Surgery ·(unknown), Jan Eva Doran, (unknown), Arlie R. Mansberger	20
19	Effect of Cold Insoluble Globulin on Carcinoma Cell Growth in vitro 1981 ·Oncology ·David C. Young, Jan Eva Doran, Arlie R. Mansberger, (unknown)	2
20	Routine laboratory assessment of postoperative chest infection: a prospective study. 1977 ·Journal of Clinical Pathology ·P. J. Wilkinson, (unknown), Jan Eva Doran, (unknown), (unknown)	10

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact